As of Sep 30
| +0.06 / +1.31%|
The 5 analysts offering 12-month price forecasts for Sangamo BioSciences Inc have a median target of 13.00, with a high estimate of 30.00 and a low estimate of 8.00. The median estimate represents a +180.78% increase from the last price of 4.63.
The current consensus among 7 polled investment analysts is to Buy stock in Sangamo BioSciences Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.